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Gap junctions (GJ) provide intercellular communication in all
multicellular animal species, being as evolutionary distant as
worm and men. In the traditional view GJs are known as spe-
cialized cell junctions forming communicating channels con-
necting the cytoplasm of adjacent cells. In almost all tissues
GJ coupled cells can rapidly exchange ions, nutrients, or small
metabolites to establish electrical coupling or balancing metabo-
lites. During the last decade our knowledge about GJ commu-
nications (GJCs) has expanded. Today, the connexins and the
second family of GJ-type proteins, the pannexins (Panx) are
known to form functional gap junctions (Cx), (hemi)channels
(Cx), and channels (Panx) permitting direct communication
between cells and between cells and the extracellular environ-
ment (Sohl et al., 2005; Sosinsky et al., 2011). Not surprisingly,
dysfunctional GJC has been incontrovertibly linked to human
disease and the number of genetic alterations found in deaf-
ness, skin disease, peripheral and central neuropathies, cataracts,
and cardiovascular dysfunctions is rapidly increasing (Zoidl
and Dermietzel, 2010). This provides an unequivocal demon-
stration that GJC is crucial for diverse physiological processes
throughout the human body. The focus of this review topic is
on delineating the most recent developments and technological
advancements in the GJ field, highlighting the fast pacing dis-
covery of dysfunctional GJC in congenital and acquired human
disease.
In “The Pannexins: Past and Present,” Bond and Naus review
the history of pannexin research, retelling the story of the dis-
covery of this phylogenetically older gene family that forms gap
junctions in invertebrates and describing the advances made
toward understanding how they influence physiology in both
health and disease (Bond and Naus, 2014).
The review “Gap junctions in C. elegans,” by Simonsen,
Moerman, and Naus, highlights innexins, the gap junction pro-
teins found in invertebrates. They are presented in the context
of offering insights into various functions of these intercellular
channels in a simple animal model that offers great potential for
genome wide functional studies (Simonsen et al., 2014).
Boyce, Wicki-Stordeur, and Swayne review on “Powerful
partnership: crosstalk between pannexin 1 and the cytoskele-
ton” providing insight how Panx1 trafficking and function
are linked to the cytoskeleton, a multi-component network
that provides critical structural support, transportation, and
scaffolding functions in all cell types (Boyce et al., 2014).
Understanding biophysical properties of connexin and pan-
nexin channels is highly relevant in the context of disease
pathophysiology and drug development. Xin and Bai review
“Functional roles of the amino terminal domain in determining
biophysical properties of Cx50 gap junction channels,” provid-
ing mechanistic insight on the roles of a particular domain of the
Cx50 gap junction channel, the major lens connexin, playing an
important role in the development of eye cataracts (Xin and Bai,
2013).
Kurtenbach, Kurtenbach, and Zoidl address the “Relevance of
gap junction communication (GJC) for heart function.” To deter-
mine the role of GJC in heart disease, they advocate for exploring
the gap junction network (GJN) using large scale data mining of
publicly available data sets from experimental and (pre)clinical
studies (Kurtenbach et al., 2014).
“The role of pannexin hemichannels in inflammation and
regeneration” by Makarenkova and Shestopalov provides an
overview how post-injury inflammatory response and the sub-
sequent process of tissue regeneration involve cell-cell com-
munication. They conclude that connexins and pannexins play
important roles in these processes and should be considered as
novel therapeutic targets (Makarenkova and Shestopalov, 2014).
“Molecular pathways of pannexin1-mediated neurotoxicity”
by Shestopalov and Slepak, reviews how Panx1 is involved in neu-
rotoxic pathways that control paracrine signaling and regulation
of the inflammasome. The most current experimental evidence
supports a model where prolonged opening of Panx1 channel
induced by danger signals trigger a cascade of neurotoxic events
capable of killing retinal ganglion cells (Shestopalov and Slepak,
2014).
The review “Influence of drugs on gap junctions in glioma cell
lines and primary astrocytes in vitro” by Moinfar, Dambach, and
Faustmann summarizes recent advances on our understanding of
GJC in different brain cells as well as in gliomas (Moinfar et al.,
2014).
The “Roles of gap junctions, connexins, and pannexins in
epilepsy” is reviewed by Mylvaganam, Ramani, Krawczyk, and
Carlen. They summarize how modulation of gap junctional
communication and altered connexin expression are intimately
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involved in the processes of epilepsy and seizures. Since specific
roles in this condition are still not fully understood, they advo-
cate for more specific modulating agents holding the promise
of better defining how these proteins modulate and are modu-
lated by seizures, both as gap junctions and membrane channels
(Mylvaganam et al., 2014).
In “Migraine with aura” a disabling primary disorder in which
patients experience visual, sensitive, or motor symptoms preced-
ing the headache is described. Sarrouilhe, Dejean, and Mesnil
present an overview of the involvement of gap junction chan-
nels between neurons and glial cells in the neocortex and the
trigeminal ganglion in the pathophysiology of this disease, pro-
viding an outlook on how gap junction channels have emerged as
a potential target in prophylaxis treatment of migraine with aura
(Sarrouilhe et al., 2014).
In the article “Relevance of gap junctions and large pore chan-
nels in traumatic brain injury” by Nora Prochnow, she addresses
the outstanding role of GJC in the pathophysiology of TBI and
links the current state of results to applied clinical procedures
as well as perspectives in acute and long-term treatment options
(Prochnow, 2014).
In closing, Meier and Rosenkranz focus on the modulation
of “Cx43 expression observed after transplantation of stem cells
in animal models of traumatic and hypoxic brain injury.” The
authors develop the intriguing hypothesis that these changes in
gap junctional communication might provide one possible expla-
nation for the beneficial effects associated with exogenous stem
cell application (Meier and Rosenkranz, 2014). Underlying mech-
anisms, including the direct communication between host cells
and transplanted cells, are discussed.
The connexin/pannexin field is now at the point where there
are numerous known hereditary connexin diseases, most of which
are believed to be due to gap junction dysfunction/expression dis-
turbance (Laird, 2014), although for some hemichannel involve-
ment has been claimed or speculated (Levit et al., 2012). There are
as yet no demonstrated pannexin diseases (Dahl and Keane, 2012;
Penuela et al., 2014; Velasquez and Eugenin, 2014), although pan-
nexin null mice exhibit abnormal behavioral phenotypes and
response to brain injury (Santiago et al., 2011; Bargiotas et al.,
2012; Gulbransen et al., 2012; Prochnow et al., 2012; Lutz et al.,
2013; Negoro et al., 2013), suggesting that brain disease or vulner-
ability to insult might arise from or gets accelerated by mutations
in pannexin genes.
Protein complexes formed by specific connexins and pannex-
ins in specific cell types under specific conditions have not yet
been extensively enough studied to enable definitive evaluation of
the roles of each of the gap junction proteins in various pathologi-
cal conditions. Studies such as those described here are beginning
to scratch the surface of this need, but are critical for development
of specific pharmacological and other therapeutic tools to selec-
tively manipulate gap junction function under physiological and
pathological conditions.
REFERENCES
Bargiotas, P., Krenz, A., Monyer, H., and Schwaninger, M. (2012). Functional out-
come of pannexin-deficient mice after cerebral ischemia. Channels (Austin) 6,
453–456. doi: 10.4161/chan.22315
Bond, S. R., andNaus, C. C. (2014). The pannexins: past and present. Front. Physiol.
5:58. doi: 10.3389/fphys.2014.00058
Boyce, A. K., Wicki-Stordeur, L. E., and Swayne, L. A. (2014). Powerful partner-
ship: crosstalk between pannexin 1 and the cytoskeleton. Front. Physiol. 5:27.
doi: 10.3389/fphys.2014.00027
Dahl, G., and Keane, R. W. (2012). Pannexin: from discovery to bedside
in 11+/-4 years? Brain Res. 1487, 150–159. doi: 10.1016/j.brainres.2012.
04.058
Gulbransen, B. D., Bashashati, M., Hirota, S. A., Gui, X., Roberts, J. A., Macdonald,
J. A., et al. (2012). Activation of neuronal P2X7 receptor-pannexin-1 medi-
ates death of enteric neurons during colitis. Nat. Med. 18, 600–604. doi:
10.1038/nm.2679
Kurtenbach, S., Kurtenbach, S., and Zoidl, G. (2014). Gap junction modu-
lation and its implications for heart function. Front. Physiol. 5:82. doi:
10.3389/fphys.2014.00082
Laird, D. W. (2014). Syndromic and non-syndromic disease-linked Cx43
mutations. FEBS Lett. 588, 1339–1348. doi: 10.1016/j.febslet.2013.
12.022
Levit, N. A., Mese, G., Basaly, M. G., and White, T. W. (2012). Pathological
hemichannels associated with human Cx26 mutations causing Keratitis-
Ichthyosis-Deafness syndrome. Biochim. Biophys. Acta 1818, 2014–2019. doi:
10.1016/j.bbamem.2011.09.003
Lutz, S. E., Gonzalez-Fernandez, E., Ventura, J. C., Perez-Samartin, A., Tarassishin,
L., Negoro, H., et al. (2013). Contribution of pannexin1 to experimen-
tal autoimmune encephalomyelitis. PLoS ONE 8:e66657. doi: 10.1371/jour-
nal.pone.0066657
Makarenkova, H. P., and Shestopalov, V. I. (2014). The role of pannexin
hemichannels in inflammation and regeneration. Front. Physiol. 5:63. doi:
10.3389/fphys.2014.00063
Meier, C., and Rosenkranz, K. (2014). Cx43 expression and function in the nervous
system-implications for stem cell mediated regeneration. Front. Physiol. 5:106.
doi: 10.3389/fphys.2014.00106
Moinfar, Z., Dambach, H., and Faustmann, P. M. (2014). Influence of drugs on
gap junctions in glioma cell lines and primary astrocytes in vitro. Front. Physiol.
5:186. doi: 10.3389/fphys.2014.00186
Mylvaganam, S., Ramani, M., Krawczyk, M., and Carlen, P. L. (2014). Roles of
gap junctions, connexins, and pannexins in epilepsy. Front. Physiol. 5:172. doi:
10.3389/fphys.2014.00172
Negoro, H., Lutz, S. E., Liou, L. S., Kanematsu, A., Ogawa, O., Scemes, E., et al.
(2013). Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis
model. Sci. Rep. 3, 2152. doi: 10.1038/srep02152
Penuela, S., Harland, L., Simek, J., and Laird, D. W. (2014). Pannexin channels and
their links to human disease. Biochem. J. 461, 371–381. doi: 10.1042/BJ20140447
Prochnow, N. (2014). Relevance of gap junctions and large pore channels in
traumatic brain injury. Front. Physiol. 5:31. doi: 10.3389/fphys.2014.00031
Prochnow, N., Abdulazim, A., Kurtenbach, S., Wildforster, V., Dvoriantchikova, G.,
Hanske, J., et al. (2012). Pannexin1 stabilizes synaptic plasticity and is needed
for learning. PLoS ONE 7:e51767. doi: 10.1371/journal.pone.0051767
Santiago, M. F., Veliskova, J., Patel, N. K., Lutz, S. E., Caille, D., Charollais, A., et al.
(2011). Targeting pannexin1 improves seizure outcome. PLoS ONE 6:e25178.
doi: 10.1371/journal.pone.0025178
Sarrouilhe, D., Dejean, C., and Mesnil, M. (2014). Involvement of gap junction
channels in the pathophysiology of migraine with aura. Front. Physiol. 5:78. doi:
10.3389/fphys.2014.00078
Shestopalov, V. I., and Slepak, V. Z. (2014). Molecular pathways of pannexin1-
mediated neurotoxicity. Front. Physiol. 5:23. doi: 10.3389/fphys.2014.00023
Simonsen, K. T., Moerman, D. G., and Naus, C. C. (2014). Gap junctions in C.
elegans. Front. Physiol. 5:40. doi: 10.3389/fphys.2014.00040
Sohl, G., Maxeiner, S., and Willecke, K. (2005). Expression and functions of
neuronal gap junctions. Nat. Rev. Neurosci. 6, 191–200. doi: 10.1038/nrn1627
Sosinsky, G. E., Boassa, D., Dermietzel, R., Duffy, H. S., Laird, D. W., Macvicar, B.,
et al. (2011). Pannexin channels are not gap junction hemichannels. Channels
(Austin) 5, 193–197. doi: 10.4161/chan.5.3.15765
Velasquez, S., and Eugenin, E. A. (2014). Role of Pannexin-1 hemichannels and
purinergic receptors in the pathogenesis of human diseases. Front. Physiol. 5:96.
doi: 10.3389/fphys.2014.00096
Xin, L., and Bai, D. (2013). Functional roles of the amino terminal domain in deter-
mining biophysical properties of Cx50 gap junction channels. Front. Physiol.
4:373. doi: 10.3389/fphys.2013.00373
Frontiers in Physiology | Membrane Physiology and Membrane Biophysics November 2014 | Volume 5 | Article 442 | 2
Zoidl and Spray Gap junctional communication in health and disease
Zoidl, G., and Dermietzel, R. (2010). Gap junctions in inherited
human disease. Pflugers Arch. 460, 451–466. doi: 10.1007/s00424-010-
l0789-1
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 12 October 2014; accepted: 29 October 2014; published online: 21     November
2014.
Citation: Zoidl G and Spray DC (2014) Gap junctional communication in health and
disease. Front. Physiol. 5:442. doi: 10.3389/fphys.2014.00442
This article was submitted to Membrane Physiology and Membrane Biophysics, a
section of the journal Frontiers in Physiology.
Copyright © 2014 Zoidl and Spray. This is an open-access article distributed under
the terms of the Creative Commons Attribution License (CC BY). The use, distribu-
tion or reproduction in other forums is permitted, provided the original author(s)
or licensor are credited and that the original publication in this journal is cited, in
accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.
www.frontiersin.org November 2014 | Volume 5 | Article 442 | 3
